Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Cheryl R. Blanchard, Ph.D., certify that:
|
1. |
I have reviewed this Amendment No. 1 on Form 10-K/A for the period ended December 31, 2023 of Anika Therapeutics, Inc.; and |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
|
Date: April 26, 2024 |
By: |
/s/ Cheryl R. Blanchard |
||
|
Cheryl R. Blanchard, Ph.D. President and Chief Executive Officer (Principal Executive Officer) |